"Die LungenClinic Grosshansdorf ist eine international anerkannte Fachklinik für sämtliche Erkrankungen der Lunge und Atemwege. Als norddeutsches Thoraxzentrum versorgt sie jährlich rund 12.000 Patienten stationär und ambulant in den Schwerpunkten Pneumologie, Onkologie, Palliativmedizin, Thoraxchirurgie und Anästhesie."

During the past decade, LungenClinic Großhansdorf GmbH conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 18 clinical trials were completed, i.e. on average, 41.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 10 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LungenClinic Großhansdorf GmbH" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "AIO-Studien-gGmbH" with 4 trials sponsored, "Aktion Bronchialkarzinom e.V." with 3 trials sponsored, "ETOP IBCSG Partners Foundation" with 3 trials sponsored and "LungenClinic Grosshansdorf" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LungenClinic Großhansdorf GmbH" #1 collaborator was "Bristol-Myers Squibb" with 3 trials as a collaborator, "German Center for Lung Research" with 3 trials as a collaborator, "Roche Pharma AG" with 3 trials as a collaborator, "Boehringer Ingelheim" with 2 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "LungenClinic Großhansdorf GmbH" are "Non-Small Cell Lung Cancer" (9 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials), "Lung Cancer" (6 trials), "Non-small Cell Lung Cancer" (5 trials) and "NSCLC" (3 trials). Many other conditions were trialed in "LungenClinic Großhansdorf GmbH" in a lesser frequency.

Most popular intervention types in "LungenClinic Großhansdorf GmbH" are "Drug" (55 trials), "Biological" (5 trials), "Device" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (14 trials), "Atezolizumab" (11 trials), "Placebo" (10 trials), "Pemetrexed" (9 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "LungenClinic Großhansdorf GmbH" are 67 trials for "All" genders.

Currently, there are NaN active trials in "LungenClinic Großhansdorf GmbH". undefined are not yet recruiting, 12 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in LungenClinic Großhansdorf GmbH, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in LungenClinic Großhansdorf GmbH, 7 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".